摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-溴甲基哌啶氢溴酸盐 | 65920-56-1

中文名称
4-溴甲基哌啶氢溴酸盐
中文别名
——
英文名称
4-(bromomethyl)piperidine hydrobromide
英文别名
4-bromomethyl-piperidine; hydrobromide;4-Brommethyl-piperidin; Hydrobromid;4-bromomethyl-piperidine hydrobromide;4-bromomethylpiperidine hydrobromide;4-(bromomethyl)piperidine;hydrobromide
4-溴甲基哌啶氢溴酸盐化学式
CAS
65920-56-1
化学式
BrH*C6H12BrN
mdl
——
分子量
258.984
InChiKey
YQNLBRMAXPPMNV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.96
  • 重原子数:
    9
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    12
  • 氢给体数:
    2
  • 氢受体数:
    1

安全信息

  • 储存条件:
    室温且干燥环境下使用。

SDS

SDS:87484d7cb99a0de8403c761ee86d5577
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 4-Bromomethylpiperidine hydrobromide
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 4-Bromomethylpiperidine hydrobromide
CAS number: 65920-56-1

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C6H12BrN.BrH
Molecular weight: 259.0

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

  • 作为反应物:
    描述:
    4-溴甲基哌啶氢溴酸盐sodium hydroxide乙醚 作用下, 生成 1-Azabicyclo<2.2.1>heptanmethoiodid
    参考文献:
    名称:
    Lukes et al., Collection of Czechoslovak Chemical Communications, 1959, vol. 24, p. 212,216
    摘要:
    DOI:
  • 作为产物:
    描述:
    4-methoxymethyl-piperidine; hydrobromide 在 氢溴酸 作用下, 生成 4-溴甲基哌啶氢溴酸盐
    参考文献:
    名称:
    A Synthesis of 3-Alkylpiperidones
    摘要:
    DOI:
    10.1021/ja01252a068
点击查看最新优质反应信息

文献信息

  • [EN] PYRAN DERVATIVES AS CYP11A1 (CYTOCHROME P450 MONOOXYGENASE 11A1) INHIBITORS<br/>[FR] DÉRIVÉS DE PYRANE EN TANT QU'INHIBITEURS DE CYP11A1 (CYTOCHROME P450 MONOOXYGÉNASE 11A1)
    申请人:ORION CORP
    公开号:WO2018115591A1
    公开(公告)日:2018-06-28
    Compounds of formula (I) wherein R1, R2,R3,R4,R5,R23,R24,L, A and Bare as defined in claim 1, or pharmaceutically acceptable salts thereof are disclosed. The compounds of formula (I) possess utility as cytochrome P450 monooxygenase 11A1(CYP11A1) inhibitors. The compounds are useful as medicaments in the treatment of steroidreceptor, particularly androgen receptor,dependent diseases and conditions, such asprostate cancer.
    公式(I)的化合物,其中R1、R2、R3、R4、R5、R23、R24、L、A和B如权利要求1中定义,或其药用可接受的盐被披露。公式(I)的化合物具有作为细胞色素P450单加氧酶11A1(CYP11A1)抑制剂的使用价值。这些化合物作为药物用于治疗激素受体,尤其是雄激素受体相关的疾病和状况,如前列腺癌。
  • Derivatives of penicillanic acid
    申请人:Leo Pharmaceutical Products, Ltd. A/S
    公开号:US04229443A1
    公开(公告)日:1980-10-21
    The present invention relates to new substituted 6.beta.-amidinopenicillanic acids; pharmaceuticallyacceptable salts, easily hydrolyzable esters thereof and salts of such esters; to methods of producing the compounds; to intermediates in their preparation, to pharmaceutical compositions containing the compounds; to dosage units thereof; and to their use.
    本发明涉及新的取代6-beta-氨基青霉烷酸衍生物;其药用盐、易水解酯及其酯的盐;制备这些化合物的方法;其制备中间体;含有这些化合物的药物组合物;其剂量单位;以及它们的用途。
  • Penicillanic acid derivatives
    申请人:Hoffmann-La Roche Inc.
    公开号:US04431653A1
    公开(公告)日:1984-02-14
    6-Amidinopenicillanic acid derivatives wherein one of the nitrogen atoms of the amidino group is part of a heterocyclic ring having on a side chain an unsubstituted heterocyclic ring containing 2 to 3 nitrogen atoms, and being useful as an antibiotic.
    其中一个氨基团的氮原子是异环戊二烯环的氨基丙酸衍生物,该异环戊二烯环的侧链含有一个未取代的异环戊二烯环,其中含有2到3个氮原子,可用作抗生素。
  • Derivatives of amidinopenicillanic acid
    申请人:Leo Pharmaceutical Products, Ltd. A/S
    公开号:US04246262A1
    公开(公告)日:1981-01-20
    The present invention relates to new 6.beta.-amidino-penicillanic acids of the formula: ##STR1## in which X is oxygen or sulphur, --A-- is aliphatic hydrocarbon, or a single bond, --B-- is aliphatic hydrocarbon, or a single bond; R.sub.1 and R.sub.2 stand for hydrogen, lower alkyl, phenyl or phenyl-lower alkyl; or R.sub.2 is acyl or guanyl; or R.sub.1 and R.sub.2 together with the nitrogen atom can form a monocyclic, saturated ring or represent ##STR2## in which R.sub.3 and R.sub.4 each stands for hydrogen, lower alkyl, phenyl, or phenyl-lower alkyl, or R.sub.3 and R.sub.4 together with nitrogen form a monocyclic, saturated ring; --W-- stands for ##STR3## which represent saturated, monocyclic, bicyclic or spirocyclic ring systems, respectively; salts of the compounds of formula I, and easily hydrolyzable, esters thereof, and salts of such esters; the invention further relating to methods of producing the compounds; to intermediates in their preparation; to pharmaceutical compositions containing the compounds; and to dosage units thereof, and to their use. The compounds of the present invention are active against a variety of pathogenic microorganisms, including gram-positive and gram-negative bacteria.
    本发明涉及新的6.beta.-酰胺基青霉烷酸,其化学式为:##STR1## 其中X为氧或硫,--A--为脂肪烃或单键,--B--为脂肪烃或单键;R.sub.1和R.sub.2代表氢、低碳基、苯基或苯基-低碳基;或R.sub.2为酰基或鸟氨酸基;或R.sub.1和R.sub.2与氮原子一起形成单环饱和环或表示##STR2## 其中R.sub.3和R.sub.4分别代表氢、低碳基、苯基或苯基-低碳基,或R.sub.3和R.sub.4与氮形成单环饱和环;--W--代表##STR3## 分别表示饱和的、单环的、双环的或螺旋的环系统;化合物I的盐以及易水解的酯和这种酯的盐;本发明还涉及制备该化合物的方法;在其制备中的中间体;含有该化合物的制药组合物;以及其用量单位和用途。本发明的化合物对各种致病微生物具有活性,包括革兰氏阳性和革兰氏阴性细菌。
  • Novel penicillanic acid derivatives
    申请人:F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft
    公开号:EP0148283A1
    公开(公告)日:1985-07-17
    @ 6-Amidinopenicillanic acid derivatives wherein one of the nitrogen atoms of the amidino group is part of a heterocyclic ring having on a side chain an unsubstituted heterocyclic ring containing 2 to 3 nitrogen atoms, with formula: wherein n is 0 or 1; is a saturated 5 to 7 membered heterocyclic ring containing the nitrogen atom as the only heteroatom, said ring being unsubstituted or substituted in one or more positions with lower alkyl; is a 5 to 7 membered heterocyclic ring having at most one additional nitrogen atom, from 0 to 2 additional double bonds, and, aside from R, either being unsubstituted or substituted in one or more positions with lower alkyl; R is lower alkyl, nitro, hydrogen,-COOH,-(CH2)y-NHR4;-(CH2)y-OR3 and R3 is hydrogen or lower alkyl, y is an integer from 0 to 4; R, is hydrogen, lower alkyl or an amino-protecting group, (Continuation next page) R5 and R6 are hydrogen or lower alkyl and R7 is lower alkylene, hydrolyzable esters thereof, salts thereof and hydrates thereof, and with formula: wherein n is an integer from 0 to 1; R, is hydrogen or lower alkyl; is a saturated 5 to 7 membered heterocyclic ring containing the nitrogen atom as the only heteroatom, said ring being unsubstituted or substituted in one or more positions with lower alkyl; is a 5 to 7 membered heterocyclic ring containing no additional double bonds or can be additionally aromatic when it is 5 membered, said ring being either unsubstituted or substituted in one or more positions with lower alkyl; and R7 is lower alkylene, hydrolyzable esters thereof, salts thereof and hydrates thereof. These compounds are useful as antibiotics.
    @ 6-脒基青霉烷酸衍生物,其中脒基的一个氮原子是一个杂环的一部分,该杂环的侧链上有一个包含 2 至 3 个氮原子的未取代杂环,其式为 其中 n 为 0 或 1; 是含有氮原子作为唯一杂原子的 5 至 7 个成员的饱和杂环,所述环未经取代或在一个或多个位置被低级烷基取代; R是低级烷基、硝基、氢、-COOH、-(CH2)y-NHR4;-(CH2)y-OR3 和-(CH2)y-OR4。 R3 是氢或低级烷基,y 是 0 至 4 的整数;R, 是氢、低级烷基或氨基保护基团, (下页接下页) R5 和 R6 是氢或低级烷基,R7 是低级亚烷基,其可水解酯、其盐和其水合物,并具有 式: 其中 n 是 0 至 1 的整数;R, 是氢或低级烷基; 是含有氮原子作为唯一杂原子的 5 至 7 个成员的饱和杂环,所述环未被取代或在一个或多个位置被低级烷基取代; R7 是低级亚烷基、其可水解酯、其盐类和其水合物。 这些化合物可用作抗生素。
查看更多